Free Trial

iTeos Therapeutics (ITOS) Earnings Date, Estimates & Call Transcripts

iTeos Therapeutics logo
$5.38 -0.32 (-5.53%)
Closing price 03:59 PM Eastern
Extended Trading
$5.39 +0.00 (+0.09%)
As of 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

iTeos Therapeutics Latest Earnings Summary

Upcoming Q1
Earnings Date
May. 9Before Market OpensEstimated
Actual EPS
(Mar. 5)
-$1.01 Beat By $0.13
Consensus EPS
(Mar. 5)
-$1.14

iTeos Therapeutics released Q4 2024 earnings on March 5, 2025, reporting an EPS of -$1.01, which topped the consensus estimate of -$1.14 by $0.13. With a trailing EPS of -$3.31, iTeos Therapeutics' earnings are expected to decrease next year, from ($3.49) to ($4.24) per share.

ITOS Upcoming Earnings

iTeos Therapeutics' next earnings date is estimated for Friday, May 9, 2025, based off prior year's reporting schedules.

Get iTeos Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on iTeos Therapeutics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

ITOS Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ITOS Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.
Remove Ads

iTeos Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20252-$1.39-$0.68-$1.04
Q2 20252-$1.44-$0.80-$1.12
Q3 20252-$1.48-$0.77-$1.13
Q4 20252-$1.53-$0.83-$1.18
FY 20258($5.84)($3.08)($4.46)
Remove Ads

iTeos Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/9/2025
(Estimated)
-------
3/5/2025Q4 2024-$1.14-$1.01+$0.13-$1.01--
11/12/2024--$1.18-$1.05+$0.13-$1.05--
8/8/2024--$1.04-$0.18+$0.86-$0.18$4.20M$35.00M
5/10/2024Q1 2024-$1.02-$1.07 -$0.05-$1.07--
3/6/2024Q4 2023-$1.03-$0.85+$0.18-$0.85$37.41M-
11/7/2023Q3 2023-$1.20-$0.90+$0.30-$0.90--
8/8/2023Q2 2023-$1.03-$0.96+$0.07-$0.96--
5/10/2023Q1 2023-$0.99-$0.44+$0.55-$0.44$13.80M$12.60M

iTeos Therapeutics Earnings - Frequently Asked Questions

iTeos Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, May 9th, 2025 based off last year's report dates. Learn more on ITOS's earnings history.

In the previous quarter, iTeos Therapeutics (NASDAQ:ITOS) reported ($1.01) earnings per share (EPS) to beat the analysts' consensus estimate of ($1.14) by $0.13. Learn more on analysts' earnings estimate vs. ITOS's actual earnings.

iTeos Therapeutics (NASDAQ:ITOS) has a recorded annual revenue of $35 million.

iTeos Therapeutics (NASDAQ:ITOS) has a recorded net income of -$112.64 million. ITOS has generated -$3.31 earnings per share over the last four quarters.

iTeos Therapeutics's earnings are expected to decrease from ($3.49) per share to ($4.24) per share in the next year.

More Earnings Resources from MarketBeat

Remove Ads


This page (NASDAQ:ITOS) was last updated on 4/4/2025 by MarketBeat.com Staff
From Our Partners